Thanks Pro for the info. Thought maquarie were the only ones non-plussed about the clinical trials. Like you said mate, good to have differing opinions on the stock.Bell Potter(Charlie Aitken) have been pretty good on this one so far and i'm hitching my barrow to them. They have received fees for share placements etc but that is of little concern to me as their analyst, Stuart Roberts i believe, seems to really have a grip on what this company is capable of achieving and their progress to date. Sort of feels like betting on a horse with these biotechs. My first time and hopefully not my last....
Thanks Pro for the info. Thought maquarie were the only ones...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |